Progyny, Inc.
PGNY
$27.12
-$0.03-0.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.31B | 1.29B | 1.29B | 1.27B | 1.24B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.31B | 1.29B | 1.29B | 1.27B | 1.24B |
| Cost of Revenue | 988.68M | 981.37M | 984.18M | 977.65M | 964.52M |
| Gross Profit | 322.09M | 311.76M | 304.48M | 291.04M | 277.44M |
| SG&A Expenses | 202.26M | 207.57M | 211.51M | 205.19M | 200.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.19B | 1.19B | 1.20B | 1.18B | 1.17B |
| Operating Income | 119.83M | 104.19M | 92.98M | 85.84M | 76.77M |
| Income Before Tax | 119.84M | 105.78M | 95.43M | 95.24M | 89.23M |
| Income Tax Expenses | 41.21M | 38.09M | 36.91M | 38.67M | 36.11M |
| Earnings from Continuing Operations | 78.63 | 67.69 | 58.52 | 56.57 | 53.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 78.63M | 67.69M | 58.52M | 56.57M | 53.12M |
| EBIT | 119.83M | 104.19M | 92.98M | 85.84M | 76.77M |
| EBITDA | 125.57M | 109.51M | 97.93M | 90.29M | 80.79M |
| EPS Basic | 0.97 | 0.81 | 0.68 | 0.66 | 0.61 |
| Normalized Basic EPS | 0.97 | 0.84 | 0.75 | 0.69 | 0.62 |
| EPS Diluted | 0.92 | 0.77 | 0.65 | 0.63 | 0.59 |
| Normalized Diluted EPS | 0.93 | 0.80 | 0.72 | 0.66 | 0.60 |
| Average Basic Shares Outstanding | 330.34M | 337.94M | 342.52M | 343.09M | 347.14M |
| Average Diluted Shares Outstanding | 346.59M | 354.08M | 358.64M | 358.09M | 361.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |